A
$ Value
$0
Shares
91,000
Price
$0
Filed
Jan 22
Insider
Name
LEWIS JOEL
Title
President and CEO
CIK
0001725595
Roles
Director
Officer
Transaction Details
Transaction Date
2026-01-16
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
91,000
Footnotes
Issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan. | The options vest as follows: 25% on each of June 30, 2026? December 31, 2026? June 30, 2027? and December 31, 2027. | The original Form 4 filed had an incorrect number of common stock options. This amendment presents the correct number of common stock options granted.
Filing Info
LEWIS JOEL's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-16 | GALT | A | $0 |
| 2026-01-16 | GALT | A | $0 |
| 2026-01-16 | GALT | A | $0 |
| 2026-01-06 | GALT | ▼ | $135K |
| 2026-01-05 | GALT | ▼ | $108K |
| 2026-01-05 | GALT | $219K | |
| 2026-01-02 | GALT | M | $0 |
| 2026-01-02 | GALT | ▼ | $78K |
| 2026-01-02 | GALT | M | $0 |
| 2025-12-17 | GALT | M | $22K |
Other Insiders at GALT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| ELDRED KARY | $810 | — | 2026-02-06 |
| Brem Henry | — | — | 2026-03-12 |